TW202304470A - 肌肉合成促進劑及p70S6K蛋白質之磷酸化促進劑 - Google Patents

肌肉合成促進劑及p70S6K蛋白質之磷酸化促進劑 Download PDF

Info

Publication number
TW202304470A
TW202304470A TW111112382A TW111112382A TW202304470A TW 202304470 A TW202304470 A TW 202304470A TW 111112382 A TW111112382 A TW 111112382A TW 111112382 A TW111112382 A TW 111112382A TW 202304470 A TW202304470 A TW 202304470A
Authority
TW
Taiwan
Prior art keywords
muscle
acid
lipoteichoic acid
gram
muscle synthesis
Prior art date
Application number
TW111112382A
Other languages
English (en)
Chinese (zh)
Inventor
河田大輔
浮辺健
瀬戸泰幸
Original Assignee
日商雪印惠乳業股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商雪印惠乳業股份有限公司 filed Critical 日商雪印惠乳業股份有限公司
Publication of TW202304470A publication Critical patent/TW202304470A/zh

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Husbandry (AREA)
  • Physiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
TW111112382A 2021-04-08 2022-03-31 肌肉合成促進劑及p70S6K蛋白質之磷酸化促進劑 TW202304470A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021065572 2021-04-08
JP2021-065572 2021-04-08

Publications (1)

Publication Number Publication Date
TW202304470A true TW202304470A (zh) 2023-02-01

Family

ID=83545422

Family Applications (1)

Application Number Title Priority Date Filing Date
TW111112382A TW202304470A (zh) 2021-04-08 2022-03-31 肌肉合成促進劑及p70S6K蛋白質之磷酸化促進劑

Country Status (3)

Country Link
JP (1) JPWO2022215568A1 (https=)
TW (1) TW202304470A (https=)
WO (1) WO2022215568A1 (https=)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013502456A (ja) * 2009-08-26 2013-01-24 アールエヌエー アイエヌシー リポタイコ酸由来の糖脂質及びこれを含む組成物
JP2013047192A (ja) * 2011-08-29 2013-03-07 Meiji Co Ltd 身体活動を促進させる乳酸菌
US20160279181A1 (en) * 2013-11-07 2016-09-29 Suntory Holdings Limited Intestinal barrier function enhancer containing lactic acid bacteria
JP6762855B2 (ja) * 2016-11-21 2020-09-30 アサヒグループホールディングス株式会社 筋肉の分解抑制剤
JP7488182B2 (ja) * 2018-06-01 2024-05-21 雪印メグミルク株式会社 筋修復促進用組成物

Also Published As

Publication number Publication date
WO2022215568A1 (ja) 2022-10-13
JPWO2022215568A1 (https=) 2022-10-13

Similar Documents

Publication Publication Date Title
AU2019243093B2 (en) Nutritional composition, food/drink composition using nutritional composition, and modified milk powder using nutritional composition
US9080219B2 (en) Bacillus amyloliquefaciens K317 for suppressing the growth of antibiotics-resistant pathogenic microorganism or enteropathogenic microorganism
ES2660813T3 (es) Nueva bacteria de ácido láctico, fármaco, producto alimenticio o bebida, y pienso que contienen la nueva bacteria de ácido láctico
WO2018145294A1 (en) Novel probiotics bifidobacteria strains
CN109996885A (zh) 乳酸菌的胞外多糖及其用途
CN105121627A (zh) 含有乳杆菌属菌的组合物
KR101109744B1 (ko) 균체외 다당을 생성하고 건강기능성 효과를 갖는 신규한 락토바실러스 파라카제이
CN111698913A (zh) 抑制脂肪蓄积用组合物
KR101109746B1 (ko) 균체외 다당을 생성하고 건강기능성 효과를 갖는 신규한 페디오코커스 펜토사세우스
KR20240118626A (ko) 락티플란티바실러스 플란타럼 y7 균주를 포함하는 장 기능 개선용 조성물
JP2018083761A (ja) 筋肉の分解抑制剤
TW201138651A (en) Agent for controlling the increase and decrease of lactobacillus bifidus in colon
JP2020164492A (ja) インドール乳酸化合物の製造方法
KR102368626B1 (ko) I형 알레르기용 조성물
CN105899090A (zh) 包含乳酸菌的肠道屏障功能促进剂
CA3163992A1 (en) Uses of lipoteichoic acid from bifidobacteria
TW202304470A (zh) 肌肉合成促進劑及p70S6K蛋白質之磷酸化促進劑
AU2017287987B2 (en) Cartilage regeneration facilitating composition
JP2015096542A (ja) 迷走神経活性化剤
KR101376629B1 (ko) 신규한 락토바실러스 아리조넨시스 ｂｃｎｕ 9200 균주 및 이를 유효성분으로 포함하는 생균제 조성물
JP2021112181A (ja) 老化細胞の蓄積抑制用組成物
KR20240115996A (ko) 신규 비피도박테리움 롱검 아종 인판티스 균주 및 이의 용도
KR20050080629A (ko) 비피도박테리움 인팬티스 Ｍａｅｉｌ-Ｋ9 유래의 세포성분함유 추출물 및 이를 함유하는 위암 및 대장암의 예방용및 치료용 조성물
WO2026038968A1 (en) Lactobacillus helveticus bgra43 strain for the treatment of liver steatosis
JP2022117889A (ja) 酸化ストレス抵抗性付与能（ｉｌ－８抑制能）及び小腸幹細胞遺伝子調節機能を有する乳酸菌